Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
. Keith Channon – a 5 year renewable award that underpins the work of the group. You will lead a programme of research in the molecular mechanisms of cardiovascular disease, that may include a range of
-
Associate will support research in the theoretical and computational mechanics of lipid membranes. This position is part of a multidisciplinary initiative focused on advancing understanding of topologically
-
policies pertaining to other schools at Duke University. The postdoc candidate is expected to: 1) Develop novel methods for incorporating scientific machine learning in solving problems in solid mechanics
-
: · MATLAB · Python · ROS · Computer vision and/or YOLO · Pytorch and/or Tensor Flow · LiDAR · GIS · GNSS receivers Minimum Qualifications: Doctoral degree in Mechanical Engineering, Electrical Engineering, or
-
, machine-learning model development, structural sensing and health monitoring, conducting physical experiments, and validation of computational models. Required Qualifications: A successful applicant must
-
personal protection equipment (PPE). Your responsibilities will encompass developing new robotic benchmarking testing setup, hardware and controller of a robotic mechanical impactor, and data acquisition
-
neuroimaging methods to investigate the cognitive and neural mechanisms of episodic memory and how they change in healthy and pathological aging. Our lab investigates cognitive and neural mechanisms of memory
-
9738BR Kate Gleason College of Engineering KGCOE Mechanical Engineering Job Summary The Fluid-Acoustic-STructure (FAST) laboratory at Rochester Institute of Technology (RIT), directed by Dr. Byron D
-
School of Medicine. The position offers a unique opportunity to contribute to a high-impact translational research program focused on the molecular and cellular mechanisms underlying pancreatic cancer
-
responses to cancer therapies in human induced pluripotent stem cells) data for elucidating molecular mechanisms for health outcomes; and 3) evaluating health disparities through pharmacogenomics